Abstract
SLV306, a potent neutral endopeptidase (NEP) inhibitor with additional endothelin-converting enzyme (ECE)-inhibitory activity, in doses of 200, 400, and 800 mg reduced pulmonary and right atrial pressures, although there was not a clear dose response. Systemic blood pressure, heart rate, and cardiac output were unaffected. SLV306 increased plasma natriuretic peptides and big endothelin-1 levels in a dose-dependent manner, confirming NEP and ECE inhibition. The combined inhibition of NEP and ECE may be useful in heart failure by reducing right and left cardiac filling pressures.
References
Mar 25, 2000·Trends in Pharmacological Sciences·G A GrayD J Webb
Sep 5, 2002·International Journal of Cardiology·Paul R KalraAndrew J S Coats
Nov 20, 2002·Circulation·Thomas F LüscherUNKNOWN Heart Failure ET(A) Receptor Blockade Trial
Dec 24, 2003·Circulation·John A SchirgerJohn C Burnett
Jan 22, 2004·Circulation·Marvin A Konstam, David DeNofrio
Citations
Apr 21, 2005·Kidney International·Fernando L MartinJohn C Burnett
Sep 19, 2009·Heart Failure Reviews·Navneet S Rehsia, Naranjan S Dhalla
Jan 26, 2010·Expert Opinion on Emerging Drugs·Reda E Girgis
Mar 10, 2016·Pharmacological Reviews·Anthony P DavenportJanet J Maguire
Oct 30, 2007·British Journal of Pharmacology·N S KirkbyD J Webb
Nov 29, 2011·British Journal of Pharmacology·Lowell LingAnthony P Davenport
Aug 2, 2011·Neurological Research·Christina WengenmayerChrista Thoene-Reineke
May 20, 2014·Pharmacology & Therapeutics·Thomas G von LuederHenry Krum
Aug 19, 2014·British Journal of Pharmacology·J J Maguire, A P Davenport
Apr 22, 2015·Current Hypertension Reports·Ludovit PaulisFedor Simko
Oct 27, 2004·Expert Review of Cardiovascular Therapy·John V Wylie, Lana Tsao
May 18, 2010·Journal of Cardiovascular Pharmacology and Therapeutics·Katherine C Wu, Gary Gerstenblith
Mar 21, 2012·Nature Reviews. Cardiology·Ludovit PaulisThomas Unger
Mar 15, 2015·Circulation Research·Suzanne Oparil, Roland E Schmieder
Jan 27, 2010·Hypertension·Kazuya MiyagawaKen-ichi Hirata
May 23, 2013·Circulation. Heart Failure·Thomas G von LuederHenry Krum
Sep 20, 2007·Journal of Cardiovascular Pharmacology·Philippe DaullBruno Battistini
Sep 21, 2019·Pharmacological Reviews·Lauren B ArendseEdward D Sturrock
Nov 14, 2013·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Matthieu MongeMichel Azizi
Mar 11, 2020·Clinica Chimica Acta; International Journal of Clinical Chemistry·Eray ErogluBengt Lindholm